The non-GAAP financial measures include: adjusted EPS, adjusted operating income, free cash flow and adjusted EBITDA. Leading in Sustainability — PolyOne and Clariant are both founding members of the Alliance to End Plastic Waste, and we are committed to meeting the needs of the present without compromising the ability of future generations to do the same. In 2021, we delivered substantial earnings growth and strong cash flow generation as we emerged from the COVID-19 pandemic.

The non-GAAP financial measures include: adjusted EPS, adjusted operating income, free cash flow and adjusted EBITDA. Leading in Sustainability — PolyOne and Clariant are both founding members of the Alliance to End Plastic Waste, and we are committed to meeting the needs of the present without compromising the ability of future generations to do the same. In 2021, we expect substantial earnings growth and strong cash flow generation as we emerge from the COVID-19 pandemic.

Avient does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for Adjusted EBITDA, Adjusted Earnings Per Share and Free Cash Flow to the most comparable GAAP financial measures on a forward-looking basis because Avient is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. Maintain asset-light, 80% free cash flow conversion profile and be valued as a specialty formulator 5. PRIOR YEAR $790 $710 2022 2023 $107 $112 2022 2023 Sales Adjusted EBITDA (in millions) $0.42 $0.47 2022 PF 2023 Adjusted EPS (in millions) - 10% + 5% + 12% Sales Adjusted EBITDA Adjusted EPS 16 $112 $500 Q4 FY $0.47 $2.30 Q4 FY Q4 AND FULL YEAR 2023 GUIDANCE $710 $3,130 Q4 FY Sales Adjusted EBITDA Adjusted EPS 17 (in millions) (in millions) Guidance: Free Cash Flow $180 $180 Prior Guidance Guidance FREE CASH FLOW & INCREASED DIVIDEND 13th Consecutive Dividend Increase 0.16 0.26 0.42 0.58 0.79 0.85 0.99 1.03 2011 2013 2015 2017 2019 2021 2023 2024 18 S U S TAI NABI L I T Y DAY RE CAP SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS 60%+ Key Growth Drivers Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other (GDP Growth) Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other (GDP growth) 0–2% Avient 6% 20 SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 8-12% Long Term Growth 50 90 2022 2030 Medical Plastics Market Size (in $Billions) 2020 2030 Recycled Plastics Virgin Plastics Growing Demand for Recycled Content Avient Sustainable Solutions 18 46 2023 2032 Global Offshore Annual Wind Installations (in Gigawatts) Sources: McKinsey, Bloomberg, Grand View Research SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 21 • Transformative acquisitions combined with divestitures of more cyclical businesses have improved margins over 400 bps since 2018 • 20% long-term margin goal to be driven by key growth drivers, with sustainable solutions playing a meaningful role 5.4% 11.5% 16.0% 2006 2018 2023E Recovery Growth Drivers Strategic Objective 20%+ +1%+ +3%+ ADJUSTED EBITDA MARGIN EXPANSION 22 • 6% annualized long-term sales growth leveraging sustainable solutions, composites, healthcare, and emerging regions • Expand EBITDA margins to 20% • Deliver annual EBITDA and EPS growth of 10% and 15% • Maintain asset-light, 80% free cash flow conversion profile and be valued as a specialty formulator • Continue fostering our Great Place to Work® culture CREATING A WORLD-CLASS SUSTAINABLE ORGANIZATION 23 PEER COMPARISONS AVIENT IS ASSET LIGHT Capex / Revenue 2023E (%) Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of December 29, 2023 Note: Avient reflects 2023 estimated revenue of $3,130 and estimated run-rate CAPEX of $110M. 26 3.5 1.8 2.7 3.1 3.3 3.7 3.0 3.7 4.7 4.8 6.8 6.8 8.7 11.1 Av ie nt KW R FU L PP G AV Y R PM FM C H U N C E EC L H XL AS H EM N SC L FREE CASH FLOW CONVERSION Source: Peer data per Bloomberg as of December 29, 2023 Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA.

The non-GAAP financial measures include: adjusted EPS, adjusted operating income, free cash flow and adjusted EBITDA. D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of October 25, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. In 2021, we expect substantial earnings growth and strong cash flow generation as we emerge from the COVID-19 pandemic.

It requires less maintenance and monitoring while also providing improved flow characteristics over rigid steel pipe.  

Improves flow and reduces the frictional resistance of end-product surfaces, enhancing both appearance and funtion.

Avient Corporation’s PCR Color Prediction Service earns 2023 Re|focus Sustainability Innovation in Design Award by The Plastics Industry Association (PLASTICS). PLASTICS’ Vice President of Sustainability, Patrick Krieger, congratulated the winners stating, “The plastic industry is innovating every day to find new ways to keep plastic in the circular economy and out of the environment. About Plastics Industry Association (PLASTICS)  

Available in a wide range of customizable colors, these impact-modified nylon formulations eliminate secondary painting processes—unlike traditional materials such as painted plastics or metals—providing the added manufacturing and sustainability benefits of reducing energy use and removing VOC emissions. TECHNICAL BULLETIN Characteristics Artisan™ Nylon Solution Painted Metal Painted Plastic Traditional Molded-in Color Impact Modified Nylon PA Ionomer Alloy Aesthetic Very Good Excellent Excellent Good Very Good Very Good Scratch Appearance Excellent Poor Poor Good Excellent Excellent Scratch & Mar Resistance Very Good Excellent Excellent Poor Very Good Excellent Color Customization Good Excellent Excellent Very Good Good Good Stress Whitening Excellent Fair Fair Poor Excellent Excellent Weatherability Good Excellent Excellent Very Good Good Very Good Temperature Performance Good Excellent Fair Fair Fair Good Corrosion Resistance Excellent Fair Excellent Excellent Excellent Excellent Processability One Step Multi Step Multi Step One Step One Step Complex One Step Total Production Cost $$$ $$$$$ $$$$ $$ $$$ $$$$ Order Quantity Restrictions Some Some Some None More More COMPARISON OF NYLON, METAL, AND PLASTIC Properties Test Method Artisan™ AR6000-0007 HI UV* Gloss Level** Gloss reading at 60 degrees 80-93 Molding Shrinkage – Across Flow ASTM D955 0.009 to 0.013 in/in Tensile Strength (Yield) ASTM D638 7300 psi Tensile Strength (Break) ASTM D638 5300 psi Tensile Elongation (Yield) ASTM D638 6.0% Flexural Modulus ASTM D790 270500 psi Flexural Strength (Yield) ASTM D790 9950 psi Notched Izod Impact ASTM D256 -4°F (-20°C) 5 ft-lb/in 73°F (23°C) 11 ft-lb/in Unnotched Izod Impact ASTM D256 -4°F (-20°C) 29 ft-lb/in 73°F (23°C) 30 ft-lb/in Color & Aesthetics*** Green, medium blue, dark blue, red, orange, white, gray, black Color customization available based on specific needs KEY PROPERTIES Features: high-gloss finish, UV stability, scratch resistance, chemical/corrosion resistance, cold temperature impact resistance, heat resistance * Reflects average of several colors, properties shift slightly depending on color ** Gloss level varies based on tooling temperature *** UV data available upon request Copyright © 2023, Avient Corporation.

Mevopur™ Healthcare Functional Additives Laser Welding Additives for Medical Devices Laser welding has become a technology of choice to join plastic parts of complex medical devices. Also known as transmission welding, laser welding is the process of using focused laser radiation to bond two plastic parts, one that is transparent to the laser energy and one that absorbs the energy. Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent implants, birth control devices, or plastic surgery.

Comptek, SilCoTec, Gordon Composites and Polystrand, including whether such businesses will be accretive, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; our ability to continue to pay cash dividends, including at the increasing rate, which will be subject to, among other factors, market conditions, our cash flow and cash requirements and restrictions contained in any of our debt agreements; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.